Biomarker-Based Clinical Trial Designs
December 9, 2010
Free Webinar on Biomarker-Based Clinical Trial Designs
- The webinar on biomarker-based clinical trial designs reviewed of the recently proposed-designs, including adaptive designs, and discussed the main issues related to their application. Their ability to validate the biomarker and/or to establish the effect of an experimental therapy in patient populations defined by the presence or absence of the biomarker is analyzed.
- It focused on biomarkers that modify the prognosis of individual patients (“prognostic” biomarkers) and biomarkers that predict how individual patients will respond to specific treatments (“predictive” biomarkers, also called “effect modifiers”). All discussed methods and concepts were illustrated by using real-life examples from oncology.
- Dr. Marc Buyse, ScD, Chairman, IDDI Consultants
- Dr. Stefan Michiels, PhD, Breast Cancer Translational Research Unit, Institut Jules Bordet, and Senior Biostatistical Consultant, IDDI
TO ACCESS THE PRESENTATION OF THIS ON-DEMAND WEBINAR, PLEASE FILL IN THE FORM BELOW